<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04854382</url>
  </required_header>
  <id_info>
    <org_study_id>REK 144084/2020</org_study_id>
    <nct_id>NCT04854382</nct_id>
  </id_info>
  <brief_title>Tailored Information About the Coronavirus in Chronic Kidney Disease Patients</brief_title>
  <acronym>TICCKD</acronym>
  <official_title>Tailored Information About the Coronavirus and the Coronavirus Pandemic for Patients With Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ivar Anders Eide</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Akershus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical trial focusing on the effect of tailored information on Covid-19 for&#xD;
      patients with chronic kidney disease on health literacy, anxiety and self-perceived health.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This single-center randomized open clinical trial in persons with chronic kidney disease&#xD;
      stage 4-5, investigates the effect of information about coronavirus specifically targeted for&#xD;
      the study population on digital, functional, interactive and critical health literacy, fear&#xD;
      of coronavirus and self-perceived health. The intervention is information videos followed by&#xD;
      a teach-back procedure. Patients are followed for 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Digital health literacy</measure>
    <time_frame>3 months</time_frame>
    <description>Digital health literacy measured by Electronic Health Literacy Scale (shortened eHEALS, Norman et al 2006), a questionnaire composed of 8 items measuring combined knowledge, comfort, and perceived skills at finding, evaluating, and applying electronic health information to health problems, Likert scale 1 (lowest, worst digital health literacy) - 5 (highest, best digital health literacy), with max score 40.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health literacy</measure>
    <time_frame>3 months</time_frame>
    <description>Health literacy measured by Health Literacy Questionnaire (shortened HLQ, Osborne et al 2013), a questionnaire composed of 44 items (9 dimensions) measuring reading and writing skills (functional), interactive and critical literacy. Likert scale 1 (lowest, worst health literacy) - 4 (highest, best health literacy) for some items and 1 (lowest, similar) - 5 (highest) for other items with calculations of mean score for each of the 9 dimensions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-perceived Health</measure>
    <time_frame>3 months</time_frame>
    <description>Self-perceived health measured with the EQ-5D-5L (EuroQol Group 1990), a questionnaire composed of 5 items / dimensions (mobility, autonomy, daily activities, pain, and anxiety and depression), Likert scale 1 (lowest / best health) - 5 (highest / worst health) with max score 25</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety / concern</measure>
    <time_frame>3 months</time_frame>
    <description>Anxiety / concern measured by the questionnaire Fear of corona scale (Ahorsu et al 2020), Likert scale 1 (lowest, least concern) - 5 (highest, most concern) with max score 35</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tailored information about coronavirus using information videos followed by a teach-back procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Controls have access to information videos, but do not receive the teach-back procedure (the intervention)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tailored information</intervention_name>
    <description>Tailored information about coronavirus for patients with chronic kidney disease by information videos followed by a teach back procedure</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic kidney disease stage 4-5&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Covid-19 during last 12 months. Dementia or other reason why cannot participate like&#xD;
             major depression, psychosis or severe frailty.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivar A Eide, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ivar A Eide, PhD</last_name>
    <phone>+47 67962699</phone>
    <email>ivar.anders.eide@ahus.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pål Gulbrandsen, Dr.med</last_name>
    <phone>+47 67900000</phone>
    <email>pal.gulbrandsen@medisin.uio.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Akershus University Hospital</name>
      <address>
        <city>Lørenskog</city>
        <state>Akershus</state>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivar A Eide, PhD</last_name>
      <phone>+47 67962699</phone>
      <email>ivar.anders.eide@ahus.no</email>
    </contact>
    <contact_backup>
      <last_name>Pål Gulbrandsen, Dr.med.</last_name>
      <phone>+47 67900000</phone>
      <email>pal.gulbrandsen@medisin.uio.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Akershus</investigator_affiliation>
    <investigator_full_name>Ivar Anders Eide</investigator_full_name>
    <investigator_title>Consultant Doctor / Researcher</investigator_title>
  </responsible_party>
  <keyword>Digital health literacy</keyword>
  <keyword>Health literacy</keyword>
  <keyword>Fear of coronavirus</keyword>
  <keyword>Self-perceived health</keyword>
  <keyword>Teach-back</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/82/NCT04854382/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

